SynthesisFrontiers in immunology2024

Pan-immune inflammation value as a prognostic biomarker for cancer patients treated with immune checkpoint inhibitors.

Tianrui Kuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.